Avidity Partners Management LP Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$2.5T
Holdings
83
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (83 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BSXBOSTON SCIENTIFIC CORP | 2,065,800 | $109.1B | 4.39% | |
| 2 | JAZZJAZZ PHARMACEUTICALS PLC | 797,500 | $103.2B | 4.16% | |
| 3 | BDXBECTON DICKINSON & CO | 286,800 | $74.1B | 2.99% | |
| 4 | NBIXNEUROCRINE BIOSCIENCES INC | 652,100 | $73.4B | 2.95% | |
| 5 | MCKMCKESSON CORP | 166,300 | $72.3B | 2.91% | |
| 6 | LEGNLEGEND BIOTECH CORP | 967,000 | $65.0B | 2.62% | |
| 7 | THCTENET HEALTHCARE CORP | 963,800 | $63.5B | 2.56% | |
| 8 | CITHE CIGNA GROUP | 207,700 | $59.4B | 2.39% | |
| 9 | IDYAIDEAYA BIOSCIENCES INC | 2,144,971 | $57.9B | 2.33% | |
| 10 | UNHUNITEDHEALTH GROUP INC | 112,200 | $56.6B | 2.28% | |
| 11 | SRPTSAREPTA THERAPEUTICS INC | 450,000 | $54.5B | 2.20% | |
| 12 | HUMHUMANA INC | 110,300 | $53.7B | 2.16% | |
| 13 | ARVNARVINAS INC | 2,614,960 | $51.4B | 2.07% | |
| 14 | ACHCACADIA HEALTHCARE COMPANY IN | 715,000 | $50.3B | 2.02% | |
| 15 | KRTXKARUNA THERAPEUTICS INC | 286,700 | $48.5B | 1.95% | |
| 16 | REGNREGENERON PHARMACEUTICALS | 58,000 | $47.7B | 1.92% | |
| 17 | ZTSZOETIS INC | 262,100 | $45.6B | 1.84% | |
| 18 | IMVTIMMUNOVANT INC | 1,173,662 | $45.1B | 1.81% | |
| 19 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 777,172 | $44.3B | 1.78% | |
| 20 | DHRDANAHER CORPORATION | 176,600 | $43.8B | 1.76% | |
| 21 | ZNTLZENTALIS PHARMACEUTICALS INC | 2,100,000 | $42.1B | 1.70% | |
| 22 | ITCIEURINTRA-CELLULAR THERAPIES INC | 801,100 | $41.7B | 1.68% | |
| 23 | SNDXSYNDAX PHARMACEUTICALS INC | 2,821,000 | $41.0B | 1.65% | |
| 24 | LLYELI LILLY & CO | 75,000 | $40.3B | 1.62% | |
| 25 | NTRANATERA INC | 899,000 | $39.8B | 1.60% | |
| 26 | ARGXARGENX SE | 80,600 | $39.6B | 1.60% | |
| 27 | SGRYSURGERY PARTNERS INC | 1,338,000 | $39.1B | 1.58% | |
| 28 | LNTHLANTHEUS HLDGS INC | 558,400 | $38.8B | 1.56% | |
| 29 | PCVXVAXCYTE INC | 756,165 | $38.5B | 1.55% | |
| 30 | 2L9BLUEPRINT MEDICINES CORP | 751,600 | $37.7B | 1.52% | |
| 31 | AKROAKERO THERAPEUTICS INC | 739,100 | $37.4B | 1.51% | |
| 32 | MIRMMIRUM PHARMACEUTICALS INC | 1,142,850 | $36.1B | 1.45% | |
| 33 | PRVAPRIVIA HEALTH GROUP INC | 1,545,100 | $35.5B | 1.43% | |
| 34 | DC4DEXCOM INC | 377,700 | $35.2B | 1.42% | |
| 35 | BHVNBIOHAVEN LTD | 1,285,400 | $33.4B | 1.35% | |
| 36 | RCKTROCKET PHARMACEUTICALS INC | 1,587,429 | $32.5B | 1.31% | |
| 37 | AMLXAMYLYX PHARMACEUTICALS INC | 1,756,940 | $32.2B | 1.30% | |
| 38 | IMGNEURIMMUNOGEN INC | 1,917,907 | $30.4B | 1.23% | |
| 39 | BIIBBIOGEN INC | 115,400 | $29.7B | 1.19% | |
| 40 | CRBUCARIBOU BIOSCIENCES INC | 6,050,212 | $28.9B | 1.16% | |
| 41 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,063,897 | $28.6B | 1.15% | |
| 42 | HCAHCA HEALTHCARE INC | 114,800 | $28.2B | 1.14% | |
| 43 | NMRANEUMORA THERAPEUTICS INC. | 1,800,000 | $25.4B | 1.02% | |
| 44 | GPCRSTRUCTURE THERAPEUTICS INC | 500,000 | $25.2B | 1.02% | |
| 45 | UHSUNIVERSAL HLTH SVCS INC | 182,000 | $22.9B | 0.92% | |
| 46 | CVACCUREVAC N V | 3,116,100 | $21.3B | 0.86% | |
| 47 | AXSMAXSOME THERAPEUTICS INC | 296,800 | $20.7B | 0.84% | |
| 48 | RAREULTRAGENYX PHARMACEUTICAL IN | 544,000 | $19.4B | 0.78% | |
| 49 | PRTAPROTHENA CORP PLC | 382,305 | $18.4B | 0.74% | |
| 50 | RVMDREVOLUTION MEDICINES INC | 657,200 | $18.2B | 0.73% | |
| 51 | CRNXCRINETICS PHARMACEUTICALS IN | 610,000 | $18.1B | 0.73% | |
| 52 | IMCRIMMUNOCORE HLDGS PLC | 348,200 | $18.1B | 0.73% | |
| 53 | ROIVROIVANT SCIENCES LTD | 1,503,302 | $17.6B | 0.71% | |
| 54 | ANTXAN2 THERAPEUTICS INC | 1,089,400 | $17.5B | 0.71% | |
| 55 | PHATPHATHOM PHARMACEUTICALS INC | 1,617,300 | $16.8B | 0.68% | |
| 56 | DNTHDIANTHUS THERAPEUTICS INC | 1,217,554 | $16.6B | 0.67% | |
| 57 | —FUSION PHARMACEUTICALS INC | 5,781,850 | $15.0B | 0.61% | |
| 58 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 643,000 | $14.0B | 0.57% | |
| 59 | VRNAVERONA PHARMA PLC | 830,300 | $13.5B | 0.55% | |
| 60 | VTYXVENTYX BIOSCIENCES INC | 354,900 | $12.3B | 0.50% | |
| 61 | NTLAINTELLIA THERAPEUTICS INC | 379,100 | $12.0B | 0.48% | |
| 62 | TVTXTRAVERE THERAPEUTICS INC | 1,323,000 | $11.8B | 0.48% | |
| 63 | SDGRSCHRODINGER INC | 399,000 | $11.3B | 0.45% | |
| 64 | KPTIEURKARYOPHARM THERAPEUTICS INC | 8,298,570 | $11.1B | 0.45% | |
| 65 | —RAYZEBIO INC | 500,000 | $11.1B | 0.45% | |
| 66 | XENEXENON PHARMACEUTICALS INC | 321,400 | $11.0B | 0.44% | |
| 67 | PACBPACIFIC BIOSCIENCES CALIF IN | 1,034,294 | $8.6B | 0.35% | |
| 68 | ACIUAC IMMUNE SA | 2,969,800 | $8.5B | 0.34% | |
| 69 | COLLCOLLEGIUM PHARMACEUTICAL INC | 350,200 | $7.8B | 0.32% | |
| 70 | NVLSEURALPINE IMMUNE SCIENCES INC | 657,280 | $7.5B | 0.30% | |
| 71 | KZRKEZAR LIFE SCIENCES INC | 6,011,100 | $7.2B | 0.29% | |
| 72 | SYRSSYROS PHARMACEUTICALS INC | 1,581,142 | $6.2B | 0.25% | |
| 73 | 2JQGRITSTONE BIO INC | 2,733,800 | $4.7B | 0.19% | |
| 74 | ATECALPHATEC HLDGS INC | 309,400 | $4.0B | 0.16% | |
| 75 | NSTGEURNANOSTRING TECHNOLOGIES INC | 2,299,100 | $4.0B | 0.16% | |
| 76 | VERVVERVE THERAPEUTICS INC | 285,334 | $3.8B | 0.15% | |
| 77 | CMPXCOMPASS THERAPEUTICS INC | 1,599,600 | $3.2B | 0.13% | |
| 78 | ALTALTIMMUNE INC | 1,159,900 | $3.0B | 0.12% | |
| 79 | SCYXSCYNEXIS INC | 1,319,444 | $3.0B | 0.12% | |
| 80 | HYPRHYPERFINE INC | 1,188,178 | $2.4B | 0.10% | |
| 81 | IPSCCENTURY THERAPEUTICS INC | 1,098,500 | $2.2B | 0.09% | |
| 82 | —CAREMAX INC | 636,000 | $1.3B | 0.05% | |
| 83 | NUVB/WSNUVATION BIO INC | 89,543 | $9.0M | 0.00% |